[
  {
    "ts": "2025-10-11T13:00:08+00:00",
    "headline": "Those who invested in Abbott Laboratories (NYSE:ABT) three years ago are up 39%",
    "summary": "Low-cost index funds make it easy to achieve average market returns. But in any diversified portfolio of stocks, you'll...",
    "url": "https://finance.yahoo.com/news/those-invested-abbott-laboratories-nyse-130008346.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "bf0e6b86-0b66-31aa-b10d-7ca43494c5c1",
      "content": {
        "id": "bf0e6b86-0b66-31aa-b10d-7ca43494c5c1",
        "contentType": "STORY",
        "title": "Those who invested in Abbott Laboratories (NYSE:ABT) three years ago are up 39%",
        "description": "",
        "summary": "Low-cost index funds make it easy to achieve average market returns. But in any diversified portfolio of stocks, you'll...",
        "pubDate": "2025-10-11T13:00:08Z",
        "displayTime": "2025-10-11T13:00:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7zJOBZ6wPnYKbKPRmWh.qQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sc9EgsXKjWnUzlOQpxWhqQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/those-invested-abbott-laboratories-nyse-130008346.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/those-invested-abbott-laboratories-nyse-130008346.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-11T00:18:00+00:00",
    "headline": "Biotech Stocks Have Struggled Since 2021. Why They’re Coming Back.",
    "summary": "Too many questionable start-ups went public during the pandemic, when the sector was hot. Now, after over four years of pain, the weak have failed, rates are falling, and M&A looks to be on the upswing.",
    "url": "https://www.barrons.com/articles/biotech-stocks-have-struggled-since-2021-why-theyre-coming-back-9d708db9?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "8f1bb26f-1684-36f6-b075-d390f064c700",
      "content": {
        "id": "8f1bb26f-1684-36f6-b075-d390f064c700",
        "contentType": "STORY",
        "title": "Biotech Stocks Have Struggled Since 2021. Why They’re Coming Back.",
        "description": "",
        "summary": "Too many questionable start-ups went public during the pandemic, when the sector was hot. Now, after over four years of pain, the weak have failed, rates are falling, and M&A looks to be on the upswing.",
        "pubDate": "2025-10-11T00:18:00Z",
        "displayTime": "2025-10-11T00:18:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/8f1bb26f-1684-36f6-b075-d390f064c700/biotech-stocks-have-struggled.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/5d0dd331e636e0ef6df76c4bfc445000",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QQ1pExlmVXCHwh6o4cycPw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/5d0dd331e636e0ef6df76c4bfc445000.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.uBeRFvbAgrcHVmqz_afng--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/5d0dd331e636e0ef6df76c4bfc445000.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/biotech-stocks-have-struggled-since-2021-why-theyre-coming-back-9d708db9?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLD"
            },
            {
              "symbol": "PLDGP"
            },
            {
              "symbol": "ABT"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]